Publications
- Classification of germline variants identified in cancer predisposition genetic testing - consensus of the CZECANCA consortium2023 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Polygenic risk score (PRS) and its potential for breast cancer risk stratification2023 | First Faculty of Medicine
- Genetic testing in ovarian cancer2022 | First Faculty of Medicine
- Další geny s rizikem vzniku nádorů prsu a ovarií2022 | First Faculty of Medicine
- Germline mutations in RAD51C and RAD51D and hereditary predisposition to ovarian cancer2021 | First Faculty of Medicine
- Germline CHEK2 Gene Mutations in Hereditary Breast Cancer Predisposition - Mutation Types and their Biological and Clinical Relevance2019 | First Faculty of Medicine
- Contribution of Massive Parallel Sequencing to Diagnosis of Hereditary Ovarian Cancer in the Czech Republic2019 | First Faculty of Medicine
- PALB2 as Another Candidate Gene for Genetic Testing in Patients with Hereditary Breast Cancer in Czech Republic2016 | First Faculty of Medicine
- CZECANCA: CZEch CAncer paNel for Clinical Application - Design and Optimization of the Targeted Sequencing Panel for the Identification of Cancer Susceptibility in High-risk Individuals from the Czech Republi2016 | First Faculty of Medicine
- Germline mutations 657del5 and 643C > T (R215W) in NBN are not likely to be associated with increased risk of breast cancer in Czech women2012 | First Faculty of Medicine
Loading network view...